PMCB icon

PharmaCyte Biotech
PMCB

Overview Fund Activity

26 hedge funds and large institutions have $1.58M invested in PharmaCyte Biotech in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
2
Increased
3
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SSA
1
Schonfeld Strategic Advisors
New York
$49.5K
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$52.7K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$94.9K
4
MCA
4
Maryland Capital Advisors
Maryland
$68
5
Jones Financial Companies
5
Jones Financial Companies
Missouri
$4

Top Sellers

1
KPF
1
K2 Principal Fund
Ontario, Canada
$400K
2
TSS
2
Two Sigma Securities
New York
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$67.3K
4
UBS Group
4
UBS Group
Switzerland
$16K
5
BlackRock
5
BlackRock
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
KFS
26
Kelly Financial Services
Massachusetts
– -$459 -234 Closed
RWMG
27
Redwood Wealth Management Group
New Jersey
– -$135 -69 Closed
1
2